Entropy Technologies LP Has $1.65 Million Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Entropy Technologies LP lowered its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 25.6% in the third quarter, Holdings Channel.com reports. The firm owned 179,537 shares of the health services provider’s stock after selling 61,883 shares during the period. Entropy Technologies LP’s holdings in Teladoc Health were worth $1,648,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TDOC. Clearline Capital LP lifted its holdings in shares of Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock valued at $42,682,000 after purchasing an additional 3,483,665 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider’s stock valued at $932,000 after acquiring an additional 63,028 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in Teladoc Health by 74.0% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock worth $311,000 after acquiring an additional 8,750 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Teladoc Health by 170.7% in the 2nd quarter. Mackenzie Financial Corp now owns 107,255 shares of the health services provider’s stock worth $1,049,000 after acquiring an additional 67,640 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its holdings in shares of Teladoc Health by 188.7% in the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock valued at $477,000 after purchasing an additional 20,651 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 9th. Evercore ISI increased their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Jefferies Financial Group boosted their price objective on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Canaccord Genuity Group decreased their target price on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. Finally, DA Davidson cut their price target on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $11.97.

Insider Transactions at Teladoc Health

In related news, CFO Mala Murthy sold 8,750 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the transaction, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas Mckinley bought 4,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was acquired at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the purchase, the director now directly owns 39,077 shares in the company, valued at approximately $300,502.13. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 20,051 shares of company stock valued at $143,565. 0.95% of the stock is currently owned by corporate insiders.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $9.71 on Wednesday. The company’s fifty day simple moving average is $8.79 and its two-hundred day simple moving average is $9.44. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. As a group, equities research analysts anticipate that Teladoc Health, Inc. will post -1.19 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.